Skip Navigation

COVID-19 Update

Practice Location

Add a Location+

Language

Add a Language+
  • A
    B
    C
    D
    E
    F
    G
    H
    I
    J
    K
    L
    M
    N
    P
    R
    S
    T
    U
    V
    Y

Doctor's Gender

Profile Results for Experimental therapeutics of acute leukemias

Displaying 4

Results per page: 10 ·  20 

  • Ivana Gojo, M.D.

    Investigation, Clinical Trials, Experimental Therapeutics of Acute Leukemias, Myelodysplastic Syndromes (MDS...

    Dr. Ivana Gojo is a Hematologist/Oncologist in Baltimore. Her clinical focus is on diagnosis and management of patients with acute leukemias (AML, ALL) and other myeloid malignancies (MDS, MPNs, CML), with emphasis on the development of novel therape...
  • Alexander Joseph Ambinder, M.D., M.P.H.

    more Research Interests Experimental Therapeutics for Acute Leukemias; Measurable Residual Disease...

    Dr. Alexander J. Ambinder is an instructor of medicine at the Johns Hopkins University School of Medicine. He is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer at Johns Hopkins. Dr. ...
  • Patrick Andrew Brown, M.D.

    Program Associate Professor of Oncology Male Expertise Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML...

    Dr. Brown's research is focused on developing new therapies for childhood leukemia. Leukemia (cancer of the blood-forming cells in the bone marrow) is the most common form of cancer in children. While great improvements have been made in the rat...
  • Jonathan Allen Webster, M.D.

    in the treatment of acute leukemias (ALL and AML...

    Dr. Webster is an Assistant Professor of Oncology at The Johns Hopkins University School of Medicine.  He is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.&n...
back to top button